Korea Investment CORP Sells 4,300 Shares of The Cooper Companies, Inc. $COO

Korea Investment CORP lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,615 shares of the medical device company’s stock after selling 4,300 shares during the quarter. Korea Investment CORP’s holdings in Cooper Companies were worth $7,222,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cooper Companies by 15.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock valued at $2,194,000 after acquiring an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC boosted its holdings in Cooper Companies by 13.4% in the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company’s stock valued at $366,000 after acquiring an additional 513 shares during the last quarter. Cerity Partners LLC boosted its holdings in Cooper Companies by 6.6% in the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company’s stock valued at $1,443,000 after acquiring an additional 1,054 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in Cooper Companies by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company’s stock valued at $1,972,000 after acquiring an additional 680 shares during the last quarter. Finally, Cetera Investment Advisers boosted its holdings in Cooper Companies by 1.3% in the fourth quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company’s stock valued at $2,211,000 after acquiring an additional 312 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the topic of several recent research reports. Piper Sandler reiterated an “overweight” rating and issued a $105.00 price target (down previously from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Mizuho decreased their price target on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Robert W. Baird cut their target price on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating on the stock in a research note on Friday, May 30th. Wall Street Zen lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Finally, Wells Fargo & Company decreased their target price on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating for the company in a research report on Friday, May 30th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $96.73.

Cooper Companies Trading Up 3.0%

NASDAQ COO opened at $75.22 on Friday. The firm has a market cap of $15.04 billion, a P/E ratio of 36.51, a P/E/G ratio of 1.78 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The stock’s 50-day moving average is $72.18 and its 200-day moving average is $78.32. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.Cooper Companies’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.85 earnings per share. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.